Empliciti Approved for Multiple Myeloma

MONDAY, Nov. 30, 2015 — Empliciti (elotuzumab), in combination with two other drugs, has been approved by the U.S. Food and Drug Administration to treat the blood cancer multiple myeloma. The drug is only approved for patients who have already been…
Source: Topamax